NAMIBIA (2012/13-2015/16)
AUDIT REPORT NO. 9-000-11-001-P | February 24, 2011
Guidelines for treatment of drug-susceptible tuberculosisand patient care
2017 Update
Points saillants des 30 pays où la charge de la tuberculose est la plus Élevée.
Pour mettre fin à la tuberculose.
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...ted. Initially, due to their high prices, affordability of DAAs was limited in high-, middle- and low-
income countries alike. Now there is a divide between those countries where, because of intellectual
property barriers, prices have remained (very) high and other countries where generics are, or can be,
available at much lower prices. The result is a dual market
more
These guidelines present evidence-based recommendations and best practice statements on use of medically important antimicrobials in food-producing animals, based on the WHO list of critically important antimicrobials for human medicine (WHO CIA List). These guidelines aim primarily to help preserve... the effectiveness of medically important antimicrobials, particularly those antimicrobials judged to be critically important to human medicine and also help preserve the effectiveness of antimicrobials for veterinary medicine, in direct support of the WHO global action plan on antimicrobial resistance
more
Guide à l’usage des établissements de santé.
Novembre 2015 Genève, Suisse.
Le présent guide présente plusieurs modèles de prise en charge différenciée, mis en oeuvre avec succès dans divers contextes et dans différents pays en Afrique subsaharienne. Il sera actualisé au fil des expé...riences rapportées concernant les démarches exposées ici ou d’autres démarches similaires.
more
Lancet Planet Health 2017 Published Online November 6, 2017 http://dx.doi.org/10.1016/S2542-5196(17)30141-9
Therapeutics Information and Pharmacovigilance Centre | TIPC